This study aims to evaluate whether an artificial intelligence (AI) based software system can assist surgeons in identifying key anatomical structures during minimally invasive upper urinary tract surgery.
During these procedures, surgeons operate while viewing images from laparoscopic endoscope. Key anatomical structures, such as the kidney, renal artery and vein, ureter, renal pelvis, inferior vena cava, and left reproductive vein, as well as surgical targets such as tumors, may sometimes be difficult to distinguish because of bleeding, surgical smoke, tissue movement, changes in tissue appearance, or obstruction by surgical instruments. The study team has developed an AI-based image recognition system that analyzes surgical video in real time and identifies and outlines relevant anatomical structures on the screen during surgery.
The study has two main goals (primary endpoints):
1. To evaluate how accurately the AI system can identify and delineate key anatomical structures in surgical videos collected from different hospitals, surgeons, surgical procedures, and imaging systems.
2. To evaluate the real-time performance and technical reliability of the AI system in the operating room, including processing latency, frame rate, system failure rate, and the proportion of time during surgery in which AI-generated results are successfully displayed.
The study will include adults aged 18 years or older who undergo one of five types of minimally invasive upper urinary tract surgery: partial nephrectomy, radical nephrectomy, radical nephroureterectomy, inferior vena cava tumor thrombectomy, or pyeloplasty.
The study will be conducted at 11 hospitals in China. In the first phase, surgical videos recorded between 2015 and 2025 will be used to develop, validate, and test the AI system. In the second phase, approximately 100 patients will be prospectively enrolled from internal centers, and the AI-generated anatomical recognition results will be displayed on a monitor during surgery. Overall, approximately 1,600 retrospective surgical cases and 100 prospective cases are planned for inclusion.
The AI system is designed solely as an assistive tool for anatomical recognition. It does not make clinical decisions, provide autonomous surgical instructions, or control any surgical equipment. Surgeons remain fully responsible for all clinical and surgical decisions, and the AI display can be turned off at any time.
All participants will receive standard clinical care. Participation in the study will not involve any additional medications, surgical procedures, or blood tests. Identifying personal information will be removed from the surgical videos and clinical data used for the study, and all study data will be stored securely in accordance with applicable data protection requirements.
As secondary objectives, the study will compare the performance of the AI system with that of surgeons with different levels of surgical experience using a set of challenging surgical images or video frames. The study will also evaluate surgeons' experience with the system, including its usability, clarity of display, and whether the AI-generated information interferes with or affects the surgical workflow.